Share
1,206 Posts.
lightbulb Created with Sketch. 116
clock Created with Sketch. 21/08/15
17:20
Share
Originally posted by absolutely clueless
↑
Matakus, that comment from Dr Mitchell Glass rekindled a thought bubble and a post I made June 30 about Pfizer being a good fit for Invion ( Pfizer and Johnson and Johnson are the 2 biggest pharma in the US). A few months back Dr Charles Mackay from Monash University was appointed Chief Scientific Officer Inflammation and Immunology Research Pfizer, Cambridge MASS. Professor Mackay is an eminent Australian immunologist. Professor Mackay is an international authority in the field of leukocyte migration. 'His research aims to understand mechanism of immune cell migration, particularly with respect to inflammation and the translation of this into new therapeutics for inflammatory diseases..'
Expand
Sorry, that post was 30th July.
